Abbvie Inc (ABBV) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abbvie Inc   (NYSE: ABBV)


Abbvie Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Abbvie Inc 's ROA in the third quarter of 2026?
Abbvie Inc achieved a return on average assets (ROA) of 7.47 % in its third quarter of 2026, which is below Abbvie Inc 's average return on assets, which stands at 7.96%.

ROA has improved compared to 4.68% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 122 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1675, from total ROA ranking in the second quarter of 2026 at 1838.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 10.29 % -1.51 % 0.42 % -0.69 % -6.64 %
Y / Y Net Income Change 2143.62 % 284.27 % -45.93 % - -87.98 %
Net Income (TTM) in million 10,346 6,316 3,641 4,233 2,395
Return On Assets (TTM) 7.47 % 4.68 % 2.69 % 3.13 % 1.77 %
ABBV's Total Ranking # 1675 # 1838 # 1908 # 1648 # 1585
Total Assets (TTM) in million 147,680 135,115 136,731 134,228 133,898
Seq. Total Assets Change 9.3 % -1.18 % 1.86 % 0.25 % -2.39 %
Seq. Net Income Change 16.65 % 418.79 % -61.6 % 865.43 % -80.02 %

ABBV's 5 Years Annual ROA >> Back to ABBV Management Effectiveness >> Compare ABBV ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 45
Sector # 123
Overall # 833

Return On Assets Statistics
High Average Low
16.46 %
7.96 %
1.77 %
(Sep. 30, 2013)   (Sep 30 2025)





Financial Statements
Abbvie Inc 's Assets $ 147,680 million ABBV's Balance sheet
Abbvie Inc 's Income $ 4,218 million Quarterly ABBV's Income Statement
ABBV's Income by Division See ABBV's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -0.69 % 0.33 % -2.95 % -5.27 % -2.68 %
Total Assets in million 134,228 135,161 134,711 138,805 146,529
Y / Y Net Income Change -1.24 % -12.05 % -58.86 % 2.56 % 149.87 %
Net Income in million 4,233 4,286 4,873 11,845 11,549
Annual Return On Assets 3.15 % 3.17 % 3.62 % 8.53 % 7.88 %

ABBV's 5 Years Annual ROA >> Back to ABBV Management Effectiveness >> Compare ABBV ROA to its Competitors



Comment on ABBV's ROA in the fiscal year ending 2025
In the fiscal year 2025 Abbvie Inc 's ROA decreased compared to previous year to 3.15 %, due to deterioration of net income -1.24 % to $4,233.00 million, from $4,286.00 million a year ago, as ABBV's assets were $134,228.00 million.


More Return On Assets Ratios
ABBV's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ABBV's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ABBV's Competitors
Subscribers only: Roa for Abbvie Inc 's Suppliers
Subscribers only: Return On Assets for ABBV's Customers

You may also want to know
ABBV's Roi ABBV's Inventory Turnover Ratio ABBV's Growth Rates ABBV's Dividend Comparisons
ABBV's Profitability Ratios ABBV's Asset Turnover Ratio ABBV's Dividend Growth
ABBV's Roe ABBV's Valuation Ratios ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Resmed Inc   18.67 %
Alector Inc   18.37 %
Corcept Therapeutics Inc  18.09 %
Chemed Corporation  17.73 %
Halozyme Therapeutics Inc   17.26 %
Pro dex Inc   16.75 %
Denali Therapeutics Inc   16.42 %
Krystal Biotech Inc   15.48 %
West Pharmaceutical Services Inc   15.47 %
Dexcom Inc   15.47 %
Intuitive Surgical Inc   14.71 %
Vertex Pharmaceuticals Inc  14.16 %
Neurocrine Biosciences Inc   13.69 %
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %

Date modified: 2026-11-04T15:04:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.